News just in
Pharmaceutical company AstraZeneca calls claims its COVID-19 vaccine is not very effective for the elderly "completely incorrect", after German media report the vaccine has an efficacy of less than 10 per cent in people over 65.
www.abc.net.au
A very weak denial, and no numbers against the age bell curve. Playing their cards tight. The smaller the sample, the lower the confidence interval. If they rejigged the doses and the interval for the elderly, then by omission, they would be covering up an earlier trial finding - leading to more approval delays. Plus the new strain may have caused an efficacy drop in a particular segment, amplified by trial country(bad luck if that was SA or Brazil).
I am sure they have smart people analyzing the numbers. It would be good if the TGA complicates matters by approving different doses tailored for different segments, and approving now, segments that are good to go.